Germline DNA damage repair variants and prognosis of patients with high-risk or metastatic prostate cancer.
Stopsack KH, Vijai J, Conry M, Berchuck JE, Kemel Y, Vasselman SE, Freeman DA, Lee GM, Mandelker D, Solit DB, Morris MJ, Penney KL, Abida W, Offit K, Mucci LA, Kantoff PW, Pomerantz MM.
Stopsack KH, et al. Among authors: conry m.
Clin Cancer Res. 2024 Oct 25. doi: 10.1158/1078-0432.CCR-24-2483. Online ahead of print.
Clin Cancer Res. 2024.
PMID: 39450704